Navigation Links
QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR
Date:4/10/2012

A feedback from the US Food and Drug Administration (FDA) in June 2012. QRxPharma's US partner for MoxDuo IR, Actavis, Inc has the option to negotiate for the US license of MoxDuo CR pending achievement of certain MoxDuo IR sales milestones in the acute pain market.

MoxDuo CR is expected to launch into the US chronic pain market in 2015.

OxyContin® and MS Contin® are registered trademarks of Purdue Pharma L.P.

About MoxDuo CR
MoxDuo CR is a patented 3:2 ratio fixed dose combination of morphine and oxycodone designed to relieve moderate to severe chronic pain as a once- to twice-a-day formulation. The MoxDuo CR formulation contains proprietary technology to limit tampering or abuse by inhalation or solubilisation in water or alcohol.

About QRxPharma
QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) is a commercial-stage specialty pharmaceutical company focused on the development and commercialisation of new treatments for pain management. Based on a development strategy that focuses on enhancing and expanding the clinical utility of currently marketed compounds, the Company's product portfolio includes both late and early stage clinical drug candidates with the potential for reduced risk, abbreviated development paths, and improved patient outcomes. QRxPharma's lead product candidate, immediate release MoxDuo, has a Prescription Drug User Fee Act (PDUFA) date of 25 June 2012 when the New Drug Application review by the US Food and Drug Administration (FDA) will be completed. The Company recently signed a strategic partnership agreement with Actavis, Inc. to commercialise MoxDuo IR in the US acute pain market, with product launch anticipated in 3Q, CY2012. QRxPharma may co-promote its products in the US and plans to seek strategic partnerships for worldwide markets. Additionally, the Company's clinical pipeline includes an intravenous (IV) and continuous release (CR) formulation of MoxDuo. For more information, vi
'/>"/>

SOURCE QRxPharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
3. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
4. QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
5. QRxPharma Inks Deal with Patheon for the Manufacture of MoxDuo(TM)CR
6. QRxPharma Limited Announces A$21.6 Million Fully Underwritten Capital Raising
7. QRxPharma Initiates Second Pivotal Phase 3 Study of MoxDuo(TM)IR Dual-Opioid(TM) for NDA Submission
8. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
9. QRxPharma Releases Additional Pivotal Phase 3 Combination Rule Study Data for MoxDuo(R)IR in Patients with Post-Surgical Pain
10. QRxPharma Successfully Completes Comparative Phase 1 Proof-of-Concept Study for MoxDuo(R) CR Tablet Formulation
11. QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 2015 Caris Life Sciences®, a leading ... precision medicine, today announced the presentation of data ... Caris Molecular Intelligence®, the company,s panomic comprehensive tumor ... share histological features. In separate presentations at the ... Oncology (ASCO) in Chicago, Ill. ...
(Date:5/29/2015)... May 29, 2015  Excite Medical was established by ... the years, Excite Medical, under the leadership of ... company, with a solid track record of providing unparalleled ... and distributor base.  Photo - ... Medical has been possible, in large part, due to ...
(Date:5/29/2015)... N.J. , May 29, 2015 A six-hour ... is being presented at the Cannabis World Congress ... New York, NY .  Taking place on ... a dedicated day of education at the leading event on ... Led by Clover Leaf University, the first ...
Breaking Medicine Technology:Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4
... AMSTERDAM, October 8 BMEYE B.V., ... its Series B financing round, raising EUR 6 million. ... Partners participated in the,financing, along with other existing BMEYE ... BMEYE has successfully been selling Nexfin(TM), ...
... Media, LLC (AHM) has acquired Ephikacy, LLC, the Chicago-based ... pharmaceutical and life sciences industries. , Advanced Health Media ... automation and compliance management systems to more than 50 ... 200 brands. The addition of Ephikacy,s product and ...
Cached Medicine Technology:BMEYE B.V. Completes EUR 6 Million Series B Financing Round 2BMEYE B.V. Completes EUR 6 Million Series B Financing Round 3Advanced Health Media Announces Acquisition of Ephikacy, LLC 2Advanced Health Media Announces Acquisition of Ephikacy, LLC 3
(Date:5/30/2015)... The results of a 40+ year ... high potential to cause mesothelioma, regardless of the volume ... on the Surviving Mesothelioma website. , The study ... Lodz, Poland found that, among the 138 cases of ... 2012, all of them happened at plants that had, ...
(Date:5/30/2015)... EHO offers a suite of online applications in ... ability to manage their drug-spend for the lowest cost ... has been able to compete with the big corporate ... among the giants of the industry. Since EHO launched ... it has simplified the way hospices can monitor patients ...
(Date:5/30/2015)... 2015 Cyclist Barry Haarde will ... the World 2015: Piles of Miles” near San ... about hemophilia and encourage individuals to support needy ... Save One Life supports nearly 1,200 impoverished children ... through direct sponsorships, scholarships and micro-enterprise grants. Hemophilia ...
(Date:5/30/2015)... FL (PRWEB) May 30, 2015 This ... partners with Pulmonary Horizons to offer one of ... effectively identify and discuss successful practices to diagnose, treat ... Attending the Pulmonary Horizons Conference is Interaction ... can address the Overall Needs of Patients with COPD," ...
(Date:5/29/2015)... Displays and Exhibits’ has recently aligned with a ... hanging signs ; making what was formerly an elite ... ceiling rigging points at a usual height of 16’-20’ are ... These signs are very unique and more visible than the ... and dismantle labor and rigging the costs far outweigh the ...
Breaking Medicine News(10 mins):Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Barry Haarde Cycles 4,000 Miles Across the USA for Hemophilia 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Displays and Exhibits Announces New Hanging Sign Supplier 2
... ... train doctors in providing proven, non-surgical relief to millions of sufferers. , ... Dallas, TX (PRWEB) November 24, ... 2010 Frozen Shoulder Syndrome Diagnosis & Treatment seminar dates today. The three-day training ...
... , ... a Leg Up From the American Podiatric Medical Association , ... Bethesda, Md. (Vocus) November 24, 2009 -- The average person ... expert and rookie travelers alike continue making their holiday travel plans, it’s easy to forget ...
... , SAN DIEGO, Nov. 24 ... Farming, Nursery and Wellness products is pleased to announce it ... (AVA) for its Aloe365(TM) Juice product. , ... very pleased to announce that we have completed the certification ...
... WASHINGTON, Nov. 24 MinuteClinic, the pioneer and largest ... has opened its first retail health care center in ... The clinic is open seven days a week and ... Langston, Kingman Park, Atlas District, Ivy City and the ...
... , 2009 Q3 Financials, S-1 Registration Statement ... , WESTON, Fla., Nov. 24 American Scientific Resources Inc. ... current corporate update. , Since filing 2007 and 2008 audited financials ... which are all part of a long term business plan for ...
... COLUMBUS, Ga., Nov. 24 Aflac Incorporated (NYSE: AFL ... the exchange of two of its investment securities owned by Aflac. ... 2009, and the exchanges are expected to settle on December 1, ... investment in Lloyds TSB Bank plc yen-denominated, Upper Tier II perpetual ...
Cached Medicine News:Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 2Health News:OTZ Announces 2010 Frozen Shoulder Syndrome Seminar Schedule 3Health News:Keep Holiday Travel Foot-Friendly 2Health News:Keep Holiday Travel Foot-Friendly 3Health News:US Farms, Inc. Receives American Vegetarian Association Certification Approval for Aloe365(TM) Juice Product 2Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 2Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 3Health News:MinuteClinic Opens First Retail Clinic in Washington, D.C. at CVS/pharmacy Store in Northeast 4Health News:American Scientific Resources Inc. Issues Corporate Update 2Health News:American Scientific Resources Inc. Issues Corporate Update 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 2Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 3Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 4Health News:Aflac To Exchange Two Lloyds Banking Group Securities, Enhance Risk-Based Capital Ratio 5
Gills Colibri forceps, very fine pointed tips....
Fine tying forceps, curved tips, wide handle....
Castroviejo tying forceps, tying platforms, straight, 0.3 mm teeth....
Microsurgical curved forceps made of titanium has curved shafts with smooth working surface. TCI working parts 6 mm from tips with round handle, diam. 6 mm, overall length 116 mm....
Medicine Products: